We Venture Capital invests in medtech companies Oxford Cancer Analytics and Proton Intelligence

by We Venture Capital

We Venture Capital, Werfen's corporate venturing arm, has made two new investments with its entry into UK-based Oxford Cancer Analytics and Canada-based Proton Intelligence. Both medical technology st...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Alantra advises Precinmac on its acquisi...

by Alantra

This transaction reinforces Alantra’s continued momentum in Aerospac...

Photos Stream